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SESSION INFORMATION
Background/Purpose:
Systemic lupus erythematosus (SLE) is an autoimmune disease that is characterized by high
morbidity and mortality and remains challenging in treatment. Dendritic cells (DCs) have been
shown to participate in the initiation and perpetuation of lupus pathogenesis. DCs that can
induce tolerogenicity appear as potential cell-based therapy in this condition. In this study, we
examined the in vitro tolerogenic properties of bone-marrow derived DCs (BMDCs) in the murine
lupus setting.
Methods:
We used lentiviral transduction of RelB-silencing shRNA to modify expression of RelB, a key
transcription factor regulating DC maturation, in BMDCs from MRL/MpJ mice. Tolerogenic
properties of RelB-modified DCs were compared to scrambled control (SC)-modified DCs.
Results:
RelB expression was found to be significantly reduced in RelB-modified DCs derived from
MRL/MpJ mice, wild type of the same genetic background as MRL/lpr lupus-prone mice. These
MRL/MpJ RelB-modified DCs displayed semi-mature phenotype with expression of lower levels of
co-stimulatory molecules compared to SC-modified DCs. RelB-modified DCs were found to be low
producer of IL-12p70, can induce hyporesponsiveness of splenic T cells from MRL/MpJ and lupus-
prone MRL/lpr mice. Furthermore, they downregulated IFN-γ expression and induced IL-10
producing T cells in MRL/MpJ splenocytes, and attenuated IFN-γ and IL-17 expression in MRL/lpr
splenic CD4+ lymphocytes. Splenocytes primed by RelB-modified DCs demonstrated antigen-
specific suppressive effect on allogeneic splenocytes.
Conclusion:
pdfcrowd.com
RelB-silencing in DCs generates DCs of tolerogenic properties with immunomodulatory function
and appears as potential option of cell-targeted therapy.
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